Document:

Exhibit
10.51

RESTRICTED STOCK UNIT AWARD AGREEMENT

UNDER THE MORGANS HOTEL GROUP CO.

2006 OMNIBUS STOCK INCENTIVE PLAN

Name of Grantee:

No. of RSUs:

Grant Date:

Pursuant to the Morgans Hotel Group Co. 2006 Omnibus Stock Incentive
Plan (the “Plan”) of Morgans Hotel Group Co. (the “Company”), a
Delaware corporation, this Restricted Stock Unit Award Agreement (this “Agreement”)
is made and entered into as this         
day of         , 2006 (the “Grant
Date”), by and between the Company and             
(the “Grantee”), for the purpose of issuing to the Grantee the number of
restricted stock units (“RSUs”) specified above (this “Award”)
under the terms and conditions set forth herein.

1.             The Plan.  This Award is made pursuant to the Plan, and
the terms of the Plan are incorporated into this Agreement, except as otherwise
specifically stated herein.  Capitalized
terms used in this Agreement that are not defined in this Agreement have the
meanings as used or defined in the Plan. 
References in this Agreement to any specific Plan provision shall not be
construed as limiting the applicability of any other Plan provision.

2.             Award.  The Company hereby grants to the Grantee         
RSUs (“Employee RSUs”) of the Company as compensation for the Grantee’s
service as an employee of the Company. 
The Employee RSU constitutes an unfunded and unsecured promise of the
Company to deliver (or cause to be delivered) to the Grantee, subject to the
terms and conditions of this Agreement, a share of Common Stock (a “Share”)
(or cash equal to the Fair Market Value thereof pursuant to Section 6) on a
Delivery Date (as defined below) (the Shares that are deliverable to the
Grantee pursuant to the RSU, the “RSU Shares”).  Until such delivery, the Grantee has only the
rights of a general unsecured creditor, and no rights as a shareholder, of the
Company.

3.             Vesting.  Except as provided in Sections 5 and 6, the
Grantee’s Employee RSUs shall vest in equal installments of 25% on the first,
second, third and fourth anniversaries of the Grant Date (which amounts may be
rounded to avoid fractional RSU Shares).

4.             Delivery.  Except as provided in Section 8, Shares
underlying the Grantee’s vested Employee RSUs (or cash equal to the Fair Market
Value thereof pursuant to Section 6) shall be delivered to the Grantee
reasonably promptly after each vesting date (each date, a “Delivery Date”
with respect to such vested Employee RSUs).

5.             Termination.  Unless the Committee determines otherwise,
and except as provided in Section 6, if the Grantee’s employment terminates
for any reason before all of the Grantee’s Employee RSUs have vested, then the
Grantee’s rights in respect of any of the

Grantee’s Employee RSUs that are not vested shall
immediately terminate and such unvested RSUs shall cease to be outstanding and
no Shares or dividend equivalent payments will be delivered in respect of such
unvested RSUs.

6.             Change in Control.  Notwithstanding any other provision of this
Agreement and the Plan, upon a Change in Control, all of the Grantee’s
outstanding Employee RSUs shall vest and the Shares underlying the Grantee’s
outstanding Employee RSUs (or cash equal to the Fair Market Value thereof)
shall be delivered to the Grantee promptly thereafter.

7.             Dividend Equivalents.  With respect to each of the Grantee’s
outstanding Employee RSUs, prior to the delivery of any RSU Shares, at or after
the time of distribution of any regular cash dividend paid by the Company in
respect of the Common Stock the record date for which occurs on or after the
Grant Date of such RSUs, the Grantee shall be entitled to receive an amount in
cash (less applicable withholding) equal to such regular dividend payment as
would have been made in respect of the RSU Shares not yet delivered (whether or
not vested), as if the RSU Shares had been actually delivered.

8.             Issuance of RSU Shares.  As promptly as is practicable after a Delivery
Date, the Company shall issue the RSU Shares registered in the name of the
Grantee, or the Grantee’s legal representative, and shall deliver certificates
representing the RSU Shares with the appropriate legends affixed thereto.  The Company may reasonably postpone such
delivery until it receives satisfactory proof that the issuance of such RSU Shares
will not violate any of the provisions of the Securities Act of 1933, as
amended, or the Securities Exchange Act of 1934, as amended, any rules or
regulations of the Securities and Exchange Commission promulgated thereunder,
or the requirements of applicable state law relating to authorization, issuance
or sale of securities, or until there has been compliance with the provisions
of such acts or rules.  The Grantee
understands that the Company is under no obligation to register or qualify the RSU
Shares with the SEC, any state securities commission or any stock exchange to
effect such compliance.

9.          Nontransferability of Employee RSUs.  These Employee RSUs may not be transferred in
any manner other than by will, by the laws of descent and distribution, or by
instruments to an inter vivos testamentary trust in which the Employee RSUs are
passed to beneficiaries upon the death of the Grantee. The terms of these Employee
RSUs shall be binding upon the executors, administrators and successors of the
Grantee.

10.        Privileges of Stock Ownership. 
The Grantee shall not have any of the rights of a stockholder of the
Company with respect to any RSU Shares until the RSU Shares are issued to the
Grantee and no adjustment shall be made for cash distributions in respect of
such RSU Shares for which the record date is prior to the date upon which such Grantee
or permitted transferee shall become the holder of record thereof.

11.        Entire Agreement.  The Plan is incorporated herein by
reference.   This Agreement, the Plan and
any such other documents as may be executed in connection with the delivery of
the RSU Shares constitute the entire agreement and understanding of the parties
hereto with respect to the subject matter hereof and supersede all prior
understandings and agreements with respect to such subject matter.  Any action taken or decision made by the

 2
 

Committee arising out of or in connection with the
construction, administration, interpretation or effect of this Agreement shall
lie within its sole and absolute discretion, as the case may be, and shall be
final, conclusive and binding on the Grantee and all persons claiming under or
through the Grantee.

12.        No Obligation to Employ. 
Nothing in the Plan or this Agreement shall confer on the Grantee any
right to continue to serve as an employee of the Company, or to continue in any
other relationship with the Company, any Parent or any Subsidiary, or limit in
any way the right of the Company, any Parent or any Subsidiary to terminate the
Grantee’s employment or other relationship at any time.

13.        Notices.  Any notice
required to be given or delivered to the Company under the terms of this
Agreement shall be in writing and addressed to the Corporate Secretary of the
Company at its principal corporate offices. 
Any notice required to be given or delivered to the Grantee shall be in
writing and addressed to the Grantee at the address last on the records of the
Company.  All notices shall be deemed to
have been given or delivered upon: 
personal delivery; three (3) days after deposit in the United States
mail by certified or registered mail (return receipt requested); one (1)
business day after deposit with any return receipt express courier (prepaid);
or one (1) business day after transmission by facsimile.

14.        Successors and Assigns. 
The Company may assign any of its rights under this Agreement. This
Agreement shall be binding upon and inure to the benefit of the successors and
assigns of the Company.  Subject to the
restrictions on transfer set forth herein, this Agreement shall be binding upon
the Grantee and the Grantee’s heirs, executors, administrators, legal
representatives, successors and assigns.

15.        Adjustments.  In the event of any change in the outstanding
Shares of the Company after the Grant Date or any other event described in
Section 5 of the Plan occurring after the Grant Date, the Board or the
Committee shall make such equitable substitution or adjustment (including cash
payments) as provided for under Section 5 of the Plan in order to preserve the
value of the Grantee’s Employee RSUs.

16.        Section 409A.  If any compensation provided by this Agreement
may result in the application of Section 409A of the Code, the Company
shall, in consultation with the Grantee modify the Agreement in the least
restrictive manner necessary in order to, where applicable, (a) exclude
such compensation from the definition of “deferred compensation” within the
meaning of such Section 409A or (b) comply with the provisions of
Section 409A, other applicable provision(s) of the Code and/or any rules,
regulations or other regulatory guidance issued under such statutory provisions
and to make such modifications, in each case, without any diminution in the
value of the payments to the Grantee.

17.        Governing Law.  This Agreement shall be governed by and
construed in accordance with the internal laws of the State of New York without
regard to that body of law pertaining to choice of law or conflict of law.

18.        Tax Withholding.  The Grantee shall, not later than the date as
of which the receipt of this Award becomes a taxable event for Federal income
tax purposes, pay to the

 3
 

Company or make arrangements satisfactory to the
Committee for payment of any Federal, state, and local taxes required by law to
be withheld on account of such taxable event. 
The Grantee may elect to have the required minimum tax withholding
obligation satisfied, in whole or in part, by authorizing the Company to
withhold from RSU Shares to be issued.

IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly
executed as of the Grant Date.

	
  

  	
  MORGANS HOTEL GROUP CO.

  
	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
   

  	
  Name:

  
	
   

  	
   

  	
  Title:

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  [Employee]

  
					

 

 4Exhibit
4.17

FORM
OF WARRANT

THE WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF
THIS WARRANT (COLLECTIVELY, THE “SECURITIES”) HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER ANY
STATE SECURITIES OR BLUE SKY LAWS (“BLUE SKY LAWS”).  NO TRANSFER, SALE, ASSIGNMENT, PLEDGE,
HYPOTHECATION OR OTHER DISPOSITION OF THIS WARRANT OR THE SECURITIES OR ANY
INTEREST THEREIN MAY BE MADE EXCEPT (A) PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT AND ANY APPLICABLE BLUE SKY LAWS OR (B) IF
THE COMPANY HAS BEEN FURNISHED WITH BOTH AN OPINION OF COUNSEL FOR THE HOLDER,
WHICH OPINION AND COUNSEL SHALL BE SATISFACTORY TO THE COMPANY, TO THE EFFECT
THAT NO REGISTRATION IS REQUIRED BECAUSE OF THE AVAILABILITY OF AN EXEMPTION
FROM REGISTRATION UNDER THE SECURITIES ACT AND APPLICABLE BLUE SKY LAWS, AND
ASSURANCES THAT THE TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER
DISPOSITION WILL BE MADE ONLY IN COMPLIANCE WITH THE CONDITIONS OF ANY SUCH
REGISTRATION OR EXEMPTION.

WARRANT

FOR

SHARES OF COMMON STOCK

OF

PROUROCARE MEDICAL INC.

	
  Warrant No.

  	
   

  	
  Plymouth, Minnesota

  
	
   

  	
   

  	
  (date)

  

 

FOR VALUE RECEIVED,                                              ,
or its successors or assigns (“Holder”), is entitled to subscribe for
and purchase from ProUroCare Medical Inc., a Nevada corporation (the “Company”),
up to                                  
fully paid and non-assessable shares of the Company’s common stock, $.00001 par
value per share (the “Common Stock”), at the price of $0.50 per share,
subject to adjustments as noted in section 3 below (the “Warrant Exercise
Price”).

This warrant may be
exercised by Holder at any time or from time to time on or prior to the fifth
anniversary of the date hereof.

This warrant is subject
to the following provisions, terms and conditions:

1.             Exercise of Warrant.  The rights represented by this warrant may be
exercised by the Holder, in whole or in part, by written notice of exercise
delivered to the Company at least three days prior to the intended date of
exercise and by the surrender of this warrant (properly endorsed if required)
at the principal office of the Company and upon payment to it by cash,
certified check or bank draft of the purchase price for such shares. The shares
so purchased shall be deemed to be issued as of the close of business on the
date on which this warrant has been exercised by its surrender and payment to
the Company of the Warrant Exercise Price. 
Certificates for the shares of stock so purchased, bearing the
restrictive legend set forth in Section 5 of this warrant, shall be delivered
to the Holder within 15 days after the rights represented by this warrant shall
have been so exercised, and, unless this warrant has expired, a new warrant
representing the number of shares, if

 1
 

any, with respect
to which this warrant has not been exercised shall also be delivered to the
Holder within such time.  No fractional
shares shall be issued upon the exercise of this warrant.

2.             Certain Covenants of the Company.  The Company covenants and agrees that all
shares that may be issued upon the exercise of the rights represented by this
warrant shall, upon issuance, be duly authorized and issued, fully paid and
non-assessable shares.  The Company
further covenants and agrees that during the period within which the rights
represented by this warrant may be exercised, the Company will at all times
have authorized, and reserved for the purpose of issue or transfer upon
exercise of the subscription rights evidenced by this warrant, a sufficient
number of shares of Common Stock to provide for the exercise of the rights
represented by this warrant.

3.             Adjustment of Exercise Price and Number of Shares.  The number of shares the Holder may purchase
and the Warrant Exercise Price shall be subject to adjustment from time to time
as hereinafter provided in this section 3.

(a)           Stock Dividend, Stock Split or
Stock Combination.  If the Company at
any time divides the outstanding shares of its Common Stock into a greater
number of shares (whether pursuant to a stock split, stock dividend or
otherwise), and conversely, if the outstanding shares of its Common Stock are
combined into a smaller number of shares, the Warrant Exercise Price in effect
immediately prior to such division or combination shall be proportionately
adjusted to reflect the reduction or increase in the value of each such Common
Stock.

(b)           Effect of Reorganization,
Reclassification or Merger.  If any
capital reorganization or reclassification of the capital stock of the Company,
or consolidation or merger of the Company with another corporation, or the sale
of all or substantially all of its assets to another corporation shall be
effected in such a way that holders of the Common Stock shall be entitled to
receive stock, securities or assets with respect to or in exchange for such
Common Stock, then, as a condition of such reorganization, reclassification,
consolidation, merger or sale, the Holder shall have the right to purchase and
receive upon the basis and upon the terms and conditions specified in this
warrant and in lieu of the shares of the Common Stock immediately theretofore
purchasable and receivable upon the exercise of the rights represented hereby,
such shares of stock, other securities or assets as would have been issued or
delivered to the Holder if it had exercised this warrant and had received such
shares of Common Stock prior to such reorganization, reclassification,
consolidation, merger or sale.

(c)           Notice of Adjustment.  Upon any adjustment of the Warrant Exercise
Price, the Company shall give written notice thereof, by first class mail,
postage prepaid, addressed to the registered Holder of this warrant at the
address of such Holder as shown on the books of the Company, which notice shall
state the Warrant Exercise Price resulting from such adjustment and the
increase or decrease, if any, in the number of shares purchasable at such price
upon the exercise of this warrant, setting forth in reasonable detail the
method of calculation and the facts upon which such calculation is based.

4.             No rights as Shareholder.  This warrant shall not entitle the Holder to
any voting rights or other rights as a shareholder of the Company.

 2
 

5.             Application of Restrictions of
Transfer.

(a)           No
transfer of this warrant may be completed unless and until (i) the Company has
received an opinion of counsel for the Company that such securities may be sold
pursuant to an exemption from registration under the Securities Act of 1933, as
amended (the “Securities Act”), or (ii) a registration statement
relating to this warrant has been filed by the Company and declared effective
by the Commission.  Subject to the
foregoing, this warrant and all rights hereunder are transferable, in whole or
in part, at the principal office of the Company by the Holder in person or by
duly authorized attorney, upon surrender of this warrant properly endorsed to
any person or entity who represents in writing that he/she/it is acquiring the
warrant for investment and without any view to the sale or other distribution
thereof.  Each Holder of this warrant, by
taking or holding the same, consents and agrees that the bearer of this
warrant, when endorsed, may be treated by the Company and all other persons
dealing with this warrant as the absolute owner hereof for any purpose and as
the person entitled to exercise the rights represented by this warrant or
perform the obligations required hereby, or to the transfer hereof on the books
of the Company, any notice to the contrary notwithstanding; but until such
transfer on such books, the Company may treat the registered owner hereof as
the owner for all purposes.

(b)           In no event shall the Holder(s) sell
any shares of Common Stock that are issued upon the exercise of the rights
represented by this warrant within 180 days following the effective date of an
initial public offering of the Common Stock of the Company.

(c)           Each
certificate for shares issued upon the exercise of the rights represented by
this warrant shall bear a legend as follows unless, in the opinion of counsel
to the Company, such legend is not required in order to ensure compliance with
the Securities Act:

“THESE SHARES HAVE BEEN PURCHASED FOR INVESTMENT WITHIN THE MEANING OF
THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND APPLICABLE STATE
SECURITIES LAWS, AND THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR
OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT
AND APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL SATISFACTORY TO
THE CORPORATION TO THE EFFECT THAT THE PROPOSED TRANSACTION WITH BE EXEMPT FROM
REGISTRATION.  IN ADDITION, IN NO EVENT
MAY THE SECURITIES REPRESENTED BY THIS CERTIFICATE BE PUBLICLY SOLD,
TRANSFERRED, ASSIGNED, OFFERED, PLEDGED OR OTHERWISE DISTRIBUTED FOR VALUE WITHIN
180 DAYS FOLLOWING THE EFFECTIVE DATE OF THE INITIAL PUBLIC OFFERING OF COMMON
STOCK BY THE COMPANY.”

6.                                       Piggyback
Registration.  

(a)           If, at any time commencing from the
date hereof and expiring four (4) years thereafter, the Company proposes to register
any of its securities under the Securities Act of 1933, as amended (the “Act”)
(other than in connection with a merger or pursuant to Form S-8, S-4 or other
comparable registration statement) it will give written notice by registered
mail, at least

 3
 

thirty (30) days
prior to the filing of each such registration statement, to the Holder and to
all other Holders of its intention to do so. 
If the Holder or other Holders notify the Company within twenty (20)
days after receipt of any such notice of its or their desire to include any
such Securities in such proposed registration statement, the Company shall
afford each of the Underwriter and such Holders the opportunity to have any
such Securities registered under such registration statement. In the event any
underwriter underwriting the sale of securities registered by such registration
statement shall limit the number of securities includable in such registration
by shareholders of the Company, the number of such securities shall be
allocated pro rata among the Holders and the holders of other securities
entitled to piggyback registration rights.

(b)           Notwithstanding the provisions of
this Section 6, the Company shall have the right at any time after it shall
have given written notice pursuant to this Section (irrespective of whether a
written request for inclusion of any such securities shall have been made) to
elect not to file any such proposed registration statement, or to withdraw the
same after the filing but prior to the effective date thereof.

(c)           Notwithstanding anything contained
herein to the contrary, the registration rights granted to each Holder by this
Section 6 shall automatically terminate on, and be of no further force or
effect from and after, the date on which such Holder can sell all of the
Securities held by such Holder without registration pursuant to Rule 144(k)
promulgated under the Securities Act of 1933, as amended (or similar exception
from registration).

7.             Governing Law. 
This Warrant shall be governed by and construed in accordance with the
laws of the State of Minnesota without regard to its conflicts-of-law
provisions.

8.             Amendments and Waivers.  The provisions of this Warrant may not be
amended, modified or supplemented, and waiver or consents to departures from
the provisions hereof may not be given, unless the Company agrees in writing
and has obtained the written consent of the Holder.

9.             Successors and Assigns.  All the terms and conditions of this Warrant
shall be binding upon and inure to the benefit of the permitted successors and
assigns of the Company and the Holder.

10.           Headings and References.  The headings of this Warrant are for
convenience only and shall not affect the interpretation of this Warrant.  Unless the context indicates otherwise, all
references herein to Sections are references to Sections of this Warrant.

11.           Notices.  All notices or communications hereunder,
except as herein otherwise specifically provided, shall be in writing.  Notices sent to the Holder shall be mailed,
hand delivered or faxed and confirmed to the Holder at his, her or its address
set forth in the Company’s records. 
Notices sent to the Company shall be mailed, hand delivered or faxed and
confirmed to ProUroCare Medical Inc., One Carlson Parkway, Suite 124, Plymouth,
Minnesota 55447, or to such other address as the Company or the Holder shall
notify the other as provided in this Section.

IN WITNESS WHEREOF, the
Company has caused this warrant to be signed and delivered by its duly
authorized officer.

	
  Dated:

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  PROUROCARE MEDICAL INC.:

  
	
   

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  
	
   

  	
  Name:

  	
  Richard C. Carlson

  
	
   

  	
  Title:

  	
  Chief Executive Officer

  
				

 

 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00120-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00120-of-00352.parquet"}]]